BlackRock »

Bridgebio Pharma shares owned by BlackRock

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $328M 13M 25.46

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
BlackRock
BlackRock
Aisling Capital Management
State Street Corporation
Susquehanna International
Henderson Group
Laurion Capital Management
Frazier Life Sciences Management
Geode Capital Management
Citadel Advisors
Pictet Asset Management Holding SA
Jane Street

View all funds holding Bridgebio Pharma